Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Blankenstein, Thomas Prof. Dr. (11) Chen, Wei Prof. Dr. (1) Daumke, Oliver Prof. Dr. (2) Fälber, Katja Dr. (1) Hammes-Lewin, Annette Dr. (1) Heinemann, Udo Prof. Dr. (1) Hirsekorn, Antje (1) Kammertöns, Thomas Dr. (2) Kieback, Elisa Dr. (1) Klußmann, Enno PD Dr. (1) Landthaler, Markus Prof. Dr. (2) Lewin, Gary Prof. Dr. (1) Obermayer-Wasserscheid, Benedikt Dr. (1) Ohler, Uwe Prof. Dr. (2) Panakova, Daniela Dr. (1) Rocks, Oliver Dr. (2) Roske, Yvette Dr. (1) Selbach, Matthias Prof. Dr. (11) Uckert, Wolfgang Prof. Dr. (3) Wanker, Erich Prof. Dr. (1) Willimsky, Gerald Dr. (4) Zauber, Henrik Dr. (3) Zühlke, Kerstin Dr. (1) (-) Bunse, Mario Dr. (1) (-) Kopp, Joachim Dr. (1) (-) Leisegang, Matthias Prof. Dr. rer. nat. (2) (-) Pezzutto, Antonio Prof. Dr. (1) (-) Wyler, Emanuel Dr. (1) 1997 (2) 1998 (2) 1999 (1) 2000 (2) 2004 (1) 2005 (2) 2006 (1) 2007 (1) (-) 2010 (2) 2011 (2) 2012 (1) 2013 (1) (-) 2016 (3) 2017 (1) 2018 (2) 2019 (1) 2020 (1) 2021 (3) 2022 (4) Cellular Neurosciences (2) Computational Regulatory Genomics (1) Experimental Ultrahigh-Field MR (4) Genome Engineering & Disease Models (2) Genomics (1) Immune Regulation and Cancer (3) Magnetic Resonance (4) Mechanism-based Cancer Therapies (1) Mobile DNA (1) (-) Molecular Immunology and Gene Therapy (4) (-) Proteome Dynamics (1) RNA Biology and Posttranscriptional Regulation (1) Transgenics (2) 5 Results: Active Filter: Bunse, Mario Dr.Kopp, Joachim Dr.Leisegang, Matthias Prof. Dr. rer. nat.Pezzutto, Antonio Prof. Dr.Wyler, Emanuel Dr.Molecular Immunology and Gene TherapyProteome Dynamics20102016 Sort: Result score Newest to oldest Oldest to newest April 15, 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner May 17, 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein February 01, 2016 / Nat Methods Detecting actively translated open reading frames in ribosome profiling data L. Calviello N. Mukherjee E. Wyler H. Zauber A. Hirsekorn M. Selbach M. Landthaler B. Obermayer U. Ohler March 01, 2010 / Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
April 15, 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner
May 17, 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau
March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
February 01, 2016 / Nat Methods Detecting actively translated open reading frames in ribosome profiling data L. Calviello N. Mukherjee E. Wyler H. Zauber A. Hirsekorn M. Selbach M. Landthaler B. Obermayer U. Ohler
March 01, 2010 / Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel